Literature DB >> 15325699

Clinical staging and prognostic markers in chronic lymphocytic leukemia.

Kanti R Rai1, Tarun Wasil, Uzma Iqbal, Nancy Driscoll, Dilip Patel, Dale Janson, Bhoomi Mehrotra.   

Abstract

In this article we provide a brief review of the two staging systems in chronic lymphocytic leukemia, and we discuss the more recently identified, new prognostic markers that are of interest to clinicians and researchers in this field.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15325699     DOI： 10.1016/j.hoc.2004.04.001

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  5 in total

Review 1.  U.S. Food and drug administration approval: rituximab in combination with fludarabine and cyclophosphamide for the treatment of patients with chronic lymphocytic leukemia.

Authors:  Sandra J Casak; Steven J Lemery; Yuan Li Shen; Mark D Rothmann; Aakanksha Khandelwal; Hong Zhao; Gina Davis; Vaishali Jarral; Patricia Keegan; Richard Pazdur
Journal:  Oncologist       Date:  2011-01-06

2.  Updating survival estimates in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) based on treatment-free interval length.

Authors:  Eric M Ammann; Tait D Shanafelt; Kara B Wright; Bradley D McDowell; Brian K Link; Elizabeth A Chrischilles
Journal:  Leuk Lymphoma       Date:  2017-07-18

3.  Prognostic information and biological insights in chronic lymphocytic leukemia by high-resolution immunophenotypic analysis of ZAP70.

Authors:  David Kaplan; Zhuoxin Sun; Martin S Tallman; Ian W Flinn; Wenbin Xiao; Paolo F Caimi; Nicholas M Kaye; Hillard M Lazarus
Journal:  Cytometry A       Date:  2014-05-20       Impact factor: 4.355

4.  B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens.

Authors:  Elena Sabattini; Rocio Orduz; Cristina Campidelli; Pier Luigi Zinzani; Vincenzo Callea; Simona Zupo; Giovanna Cutrona; Fortunato Morabito; Manlio Ferrarini; Stefano Pileri
Journal:  J Clin Pathol       Date:  2006-08-17       Impact factor: 3.411

5.  Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.

Authors:  Elizabeth S Raveche; Erica Salerno; Brian J Scaglione; Vijaya Manohar; Fatima Abbasi; Yi-Chu Lin; Torgny Fredrickson; Pablo Landgraf; Sumant Ramachandra; Konrad Huppi; Jorge R Toro; Vincent E Zenger; Robert A Metcalf; Gerald E Marti
Journal:  Blood       Date:  2007-03-09       Impact factor: 22.113
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.